Canary Capital Group LLC ("Canary Capital"), a digital asset investment management firm, today announced the launch of the Canary Staked INJ ETF (Ticker: INJC), listed on Nasdaq. The Fund seeks to provide exposure to the price of INJ, the native token of the Injective blockchain network. In addition, the Fund also seeks to earn additional INJ through participation in the Injective network's proof-of-stake validation process, with net staking rewards reflected in the Fund's net asset value.
See INJC on the official Nasdaq page.
"The Canary Staked INJ ETF gives investors access to a blockchain purpose-built for finance through a familiar exchange-traded structure, while also enabling investors to benefit from potential staking rewards," said Steven McClurg, CEO of Canary Capital. "Injective was designed from the ground up for trading, tokenization, markets, and financial applications. We believe investors are increasingly looking past the largest digital assets and toward the specialized networks building the next generation of on-chain financial infrastructure."
Injective is a Layer-1 blockchain designed to serve as the technological foundation for on-chain finance. Its purpose-built architecture offers developers pre-built, plug-and-play financial modules, including a fully onchain order book exchange module, enabling rapid development of tokenization, trading, derivatives, and other financial applications. INJ is used to secure the network through staking, to participate in governance, and to pay transaction and trading fees.
The network also features a unique Community Buyback mechanism that regularly removes INJ from circulation using a portion of revenue generated by applications on the network. Injective has tokenized over $1 Billion in assets to date*, ranking it among the top blockchains for Real-World Assets (RWAs). As of October 22nd, 2026, Injective had processed more than 3.13 billion transactions and permanently burned more than 7.27 million INJ (~$58 million USD) across its monthly token buybacks. In addition, the analytics platform Token Terminal reports approximately 257,300* monthly active addresses on Injective.
Recent upgrades include Injective Mint, which enables institutions to issue and manage tokenized assets with controls over ownership and transfers. Injective also showcased CypherOS which provides a full stack privacy platform capable of enabling confidential trading, transactions and tokenization. Also, over $25 million* of the native USDC stablecoin has been issued on Injective to support payments and settlement across the network.
“Investors can now gain exposure to INJ through the brokerage accounts they already use,” said Eric Chen, Co-Founder of Injective Foundation. “We built Injective to bring financial markets onchain. Canary’s launch connects that mission to a broader base of investors, giving them a familiar way to access the asset that powers Injective.”
For more information on INJC, click here.
About Injective
Injective is the first blockchain purpose-built for finance, enabling users, institutions, and AI agents to trade, tokenize, and transact at scale. Proudly made in America, Injective provides foundational blockchain infrastructure for global markets, with embedded financial primitives spanning stablecoins, real-world assets, payments, and programmable perpetuals through a unified onchain engine. Injective is used by Fortune 500 companies, banks, fintechs, and governments to power an open economy where any asset can be accessed anytime, from anywhere. Builders can deploy across multiple virtual machines like WASM and EVM, connect to native financial modules, and launch markets with deep liquidity from day one. INJ is the native token powering the rapidly growing Injective ecosystem and the new internet economy.
Website | Telegram | Discord | Blog | Twitter/X | Youtube | Facebook | LinkedIn | Reddit | Instagram | Orbit Newsletter
